SCHEMBL7212083

SCHEMBL7212083

COc1ccc(S(=O)(=O)C(C)CC(S)C(=O)O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 9/20 0.49
MMP1 P03956 8/20 0.49
MMP2 P08253 5/20 0.48
MMP3 P08254 4/20 0.48
PDE4A P27815 2/20 0.48
PDE4B Q07343 2/20 0.48
PDE4C Q08493 2/20 0.48
PDE4D Q08499 2/20 0.48
NPC1 O15118 2/20 0.46
ALDH1A1 P00352 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
TDP1 Q9NUW8 1/20 0.46
SLC1A3 P43003 1/20 0.46
SLC1A2 P43004 1/20 0.46
SLC1A1 P43005 1/20 0.46
HTT P42858 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7207763 0.84 MMP1 (0.49) MMP13MMP1MMP2MMP3PDE4A
SCHEMBL7352846 0.77 MMP13 (0.60) MMP13MMP1MMP2MMP3PDE4A
SCHEMBL7415077 0.77 MMP9 (0.53) MMP13MMP1MMP2MMP3PDE4A
SCHEMBL7207037 0.75 MMP1 (0.55) MMP13MMP1MMP2MMP3PDE4A
SCHEMBL7411621 0.74 MMP13 (0.57) MMP13MMP1MMP2NPC1RAB9A
SCHEMBL8713408 0.74 MMP1 (0.51) MMP13MMP1MMP2MMP3PDE4A
SCHEMBL6929276 0.74 MMP1 (0.70) MMP13MMP1MMP2MMP3PDE4A
SCHEMBL7207035 0.74 MMP1 (0.54) MMP13MMP1MMP2MMP3PDE4A
SCHEMBL7207026 0.74 MMP13 (0.68) MMP13MMP1MMP2MMP3MMP9
SCHEMBL7207685 0.74 MMP13 (0.51) MMP13MMP1MMP2MMP3SLC1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0939628-B1 THIOL SULFONE METALLOPROTEASE INHIBITORS MONSANTO CO (US) 2003-03-05 EP disclosed
US-6013649-A BOND DISORDERS; AUTOIMMUNE DISEASES; ANTITUMOR AGENTS MONSANTO COMPANY (US) 2000-01-11 US disclosed